CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Total revenue	$ 30,616	$ 29,619
Depreciation and amortization	1,503	1,278
Total cost of sales	18,434	18,658
Gross profit	12,182	10,961
Operating expenses:
Research and development expenses	1,571	3,170
Selling, general and administrative expenses	19,633	16,229
Total operating expenses	21,204	19,399
Operating loss	(9,022)	(8,438)
Other income	561	1,252
Interest expense	(147)	(175)
Loss before income taxes	(8,608)	(7,361)
Benefit from (provision for) income taxes	4	(17)
Net loss	$ (8,604)	$ (7,378)
Net loss per share:
Basic (in dollars per share)	$ (0.12)	$ (0.10)
Diluted (in dollars per share)	$ (0.12)	$ (0.10)
Weighted-average shares outstanding:
Basic (in shares)	72,715	70,628
Diluted (in shares)	72,715	70,628
Service
Total revenue	$ 28,845	$ 28,851
Cost of sales	15,491	17,059
Product
Total revenue	1,771	768
Cost of sales	$ 1,440	$ 321